Translational Oncology Intelligence
Precision oncology demands accurate interpretation of increasingly complex genomic data. Every case requires correlating somatic variants, copy-number alterations, gene fusions, MSI, TMB, and other biomarkers against current clinical evidence, therapeutic guidelines, and actionable targets. With compounding evidence, manual interpretation becomes the primary bottleneck — slowing turnaround time, introducing inconsistency, and limiting scale.
Impactomics accelerates end-to-end oncology interpretation through AI-powered biomarker prioritization, integrated evidence aggregation, AMP/ASCO/CAP-compliant classification, and automated reporting. Deliver high-quality precision oncology reports at the speed and scale the field now demands.
Transformative Consulting Offerings
We design and optimize end to end NGS pipelines, automating QC, variant calling, annotation and regulatory grade reporting. Harmonize multi-omics data and migrate bioinformatics to cloud-native platforms for reproducible diagnostics.
We build HIPAA and GDPR compliant data lakes, that enable firms to migrate their legacy systems to cloud microservices, implement FHIR, HL7, OMOP and GA4GH interoperability. Enable federated learning to train secure cross institutional AI.
We advise labs on LIMS and ELN modernization. We also design API first microservices to replace monoliths, craft clinician friendly UX, dashboards, and AI copilots that streamline workflows and accelerate decision making.
We design infrastructure and workflows meeting HIPAA, GDPR, CLIA and CAP. Implement auditability, logging, governance; apply threat modeling, encryption and secure APIs to protect patient genomics and clinical data at scale.
We implement AI diagnostic systems for variant interpretation, risk stratification, and predictive modeling. Integrate Gen AI for literature synthesis and matching. Leverage agentic workflows and digital twins to personalize and accelerate decisions.
Offerings and Key Features
in one automated pipeline.
AMP/ASCO/CAP guidelines to every somatic variant, consolidating therapeutic, prognostic, diagnostic,
and predictive evidence from curated oncology knowledgebases. Routine interpretation is automated. Experts remain in control throughout.
Then matched against approved therapies, companion diagnostics, resistance biomarkers, etc. Clinical teams receive decision-ready findings, not raw variant lists.
and research use, export-ready
from day one.
with CIViC, ClinVar, cBioPortal, BRCAExchange, PharmGKB, ClinGen, and clinical trial registries. Evidence
is continuously updated and embedded at the point of interpretation.
Real-world Impact Starts Here
Intelligence
Every significant biomarker correlates automatically with FDA-approved therapies, companion diagnostics, NCCN guidelines, and clinical trials – within one workflow, without manual searches or fragmented evidence.
-1.png?width=51&name=Vector%20(4)-1.png)
Platform
Built for somatic DNA analysis today and engineered for RNA, proteomics, and emerging multi-omics tomorrow, so laboratories evolve without replacing their technology stack.
Enterprise Scale
Secure, cloud-native architecture processes high-volume oncology cohorts with speed and elasticity, scaling to meet growing clinical and research demands while reducing infrastructure overhead.
What Leaders Can Expect
(Oncologists, Pathologists, CMOs)
Receive AMP/ASCO-classified somatic reports with FDA drug options and clinical trial matches at point of review — structured for the next tumor board, not the next working day.
(Lab Directors, Genome Analysts)
Automate somatic variant calling, biomarker scoring, and tier classification across all panel types. Scale oncology throughput without expanding the bioinformatics team or fragmenting the toolchain.
(Research Heads, Bioinformaticians)
Access structured somatic outputs, biomarker profiles, and multi-gene signatures that feed directly into cohort assembly, clinical trial matching, and translational research workflows.
Related Solutions
.jpg?width=300&name=048fe5e71d05e92b27c3f32758269d2404fe5aff%20(1).jpg)
Deploy containerized NGS workflows on cloud-native infrastructure. Automate variant calling, annotation, and reporting for high-throughput genomic diagnostics and research.
Deploy containerized NGS workflows on cloud-native infrastructure. Automate variant calling, annotation, and reporting for high-throughput genomic diagnostics and research.
Deploy containerized NGS workflows on cloud-native infrastructure. Automate variant calling, annotation, and reporting for high-throughput genomic diagnostics and research.
Drive more intelligence from tumor
sequencing to treatment decision